ArticleDigestive diseases and sciences2022

Inflammatory Bowel Disease Patients Who Respond to Treatment with Anti-tumor Necrosis Factor Agents Demonstrate Improvement in Pre-treatment Frailty.

Bharati D Kochar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.